SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Munch-a-Biotech Today
An SI Board Since December 1998
Posts SubjectMarks Bans
3158 136 0
Emcee:  Biomaven Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1508Awful story. A CEO, trying to make a move that would provide for a depth/breadtscaram(o)uche-4/14/2003
1507Biotech firm falls victim to hostile takeover Simon Bowers Saturday April 12, 2Icebrg-4/14/2003
1506First hostile bid in the sector in years. Reuters UPDATE - Axcan Pharma says brkrw-4/10/2003
1505VANCOUVER (Dow Jones)--Inflazyme Pharmaceuticals Ltd. and GlycoDesign Inc. have nigel bates-4/9/2003
1504>>BILLERICA, Mass. and MADISON, Wis.--(BUSINESS WIRE)--April 7, 2003-- Cotuck-4/7/2003
1503Private munch: >>DAVIS, Calif., April 2 /PRNewswire/ -- Sagres Discovery tuck-4/2/2003
1502UK biotech investor Evans joins OGS bid war By Mark Potter LONDON, April 1 (Reunigel bates-4/2/2003
1501IVGN munches VRTX' PanVera: Message 18777219 A good idea for both, IMO. Ctuck-3/31/2003
1500Idenix is the old "Novirio". At least some of the VC funding is descrscaram(o)uche-3/26/2003
1499Oxford Glycosciences Plc ('OGS' or the 'Company') Update on MergIcebrg-3/26/2003
1498Majority Interest in Idenix Pharmaceuticals, an MPM Capital Portfolio Company, tnigel bates-3/26/2003
1497Veteran deal-maker Fellner drives UK biotech M&A By Mark Potter LONDON, Manigel bates-3/21/2003
1496Vernalis could be an interesting munch candidate. Message 18731308 Worse than exnigel bates-3/21/2003
1495<pre>...3. Background to the merger British Biotech and RiboTargets anigel bates-3/21/2003
1494<pre>PROPOSED MERGER OF BRITISH BIOTECH AND RIBOTARGETS The boards of Brinigel bates-3/21/2003
1493This is by no means a conclusive argument, but it is one that any company proposnigel bates-3/6/2003
1492Screw Celltech.scaram(o)uche-3/6/2003
1491Well CELG is nearing breakeven going forward, so a munch is certainly feasible fBiomaven-3/6/2003
1490Briefing reports a CELG rumor: <i>Also on trading floors is rumor of a CEtom pope-3/6/2003
1489Oxford Glycosciences Plans To Adjournment Meeting Thursday March 6, 9:10 am ET scaram(o)uche-3/6/2003
1488Some more on the ongoing Novartis/Roche saga: <i>Novartis weighs run on RBiomaven-3/5/2003
1487Some comments from FT's Lex on the latest moves in the CAT/OGS soap. Immuno-Icebrg-2/27/2003
1486<i>Great piece of opportunism by DNDN.</i> NEW YORK (Dow Jones)--Denigel bates-2/25/2003
1485SEATTLE & SAN DIEGO--(BUSINESS WIRE)--Feb. 25, 2003--Dendreon (Nasdaq:DNDN -nigel bates-2/25/2003
1484GAITHERSBURG, Md.--(BUSINESS WIRE)--Feb. 25, 2003--Gene Logic Inc. (Nasdaq: GLGCnigel bates-2/25/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News